TABLE 3.
Adverse events the first 4 weeks of patiromer treatment
| Adverse event | Any diuretic (n = 132) | No diuretic (n = 111) |
| Reporting any AE, n (%) | 68 (51.5) | 46 (41.4) |
| Seriousa | 3 (2.3) | 0 |
| Leading to discontinuation | 9 (6.8) | 6 (5.4) |
| Most common AEs, n (%)b | ||
| Constipation (none severe) | 10 (7.6) | 16 (14.4) |
| Diarrhea (none severe) | 7 (5.3) | 1 (0.9) |
AE, adverse event.
aNone of the serious AEs were considered related to patiromer by the investigators.
bOccurring in 5% or more of patients in either subgroup.